Skip to main content
. 2020 Sep 21;103(6):2492–2500. doi: 10.4269/ajtmh.20-0209

Table 3.

Univariate and multivariable associations between adolescent characteristics and TB treatment unfavorable outcome

Characteristic Univariate logistic model Multivariate logistic model
OR (95% CI) P-value Adjusted OR (95% CI) P-value
Age (years)
 10–14 Reference
 15–16 0.63 (0.33–1.21) 0.166 0.54 (0.26–1.10) 0.091
 17–18 1.25 (0.72–2.14) 0.425 1.20 (0.65–2.21) 0.552
Type of TB
 New case Reference
 Retreatment 4.38 (2.37–8.08) < 0.001 4.51 (2.23–9.17) < 0.001
Residence area/districts
 2.0 Reference
 3.1 4.02 (1.85–8.72) < 0.001 4.11 (1.79–9.46) < 0.001
 3.3 4.82 (2.14–10.87) < 0.001 5.35 (2.20–13.03) < 0.001
 Other 2.05 (0.97–4.33) < 0.059 1.77 (0.81–3.87) 1.159
TB–HIV coinfection
 HIV negative Reference
 HIV positive 11.69 (5.21–26.24) < 0.001 10.15 (4.15–25.34) < 0.001
 Not performed/missing data 1.34 (0.77–2.35) 0.301 1.02 (0.54–1.89) 0.970
Extreme vulnerability
 No Reference
 Yes 3.31 (1.99–5.51) < 0.001 3.01 (1.70–5.33) < 0.001
Direct observed treatment
 No Reference
 Yes 0.76 (0.46–1.26) 0.291 1.10 (0.61–1.97) 0.749
 Missing data 1.55 (0.88–2.75) 0.129 2.48 (1.31–4.96) 0.006
Gender
 Female Reference
 Male 0.70 (0.47–1.05) 0.086
TB form
 Pulmonary Reference
 Pulmonary + extrapulmonary 0.62 (2.74–1.40) 0.25
Homeless
 No Reference
 Yes 9.88 (2.82–34.45) < 0.001
Inmates
 No Reference
 Yes 1.02 (0.22–4.77) 0.607
Illicit drug use
 No Reference
 Yes 4.44 (2.47–7.97) < 0.001
Alcohol abuse
 No Reference
 Yes 5.7 (1.80–18.02) 0.005
Comorbidities
 No Reference
 Yes 3.66 (0.49–27.65) 0.208
Tobacco use
 No Reference
 Yes 2.44 (1.12–5.29) 0.028
Xpert testing
 Yes Reference
 No 0.73 (0.63–1.39) 0.735
Xpert testing result
 RIF sensitive Reference
 RIF resistant 2.06 (0.38–11.30) 0.404
Baseline drug susceptibility testing performed
 Yes Reference
 No 1.25 (0.82–1.92) 0.291

OR = odds ratio; RIF = rifampicin; TB = tuberculosis.